skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 1,884  for All Library Resources

Results 1 2 3 4 5 next page
Show only
Result Number Material Type Add to My Shelf Action Record Details and Options
1
KESTREL and KITE: 52-Week Results From Two Phase III Pivotal Trials of Brolucizumab for Diabetic Macular Edema
Material Type:
Article
Add to My Research

KESTREL and KITE: 52-Week Results From Two Phase III Pivotal Trials of Brolucizumab for Diabetic Macular Edema

American journal of ophthalmology, 2022-06, Vol.238, p.157-172 [Peer Reviewed Journal]

2022 ;Copyright © 2022. Published by Elsevier Inc. ;Copyright Elsevier Limited Jun 2022 ;ISSN: 0002-9394 ;EISSN: 1879-1891 ;DOI: 10.1016/j.ajo.2022.01.004 ;PMID: 35038415

Full text available

2
Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema
Material Type:
Article
Add to My Research

Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema

The New England journal of medicine, 2015-03, Vol.372 (13), p.1193-1203 [Peer Reviewed Journal]

Copyright © 2015 Massachusetts Medical Society. All rights reserved. ;Copyright © 2015 Massachusetts Medical Society. 2015 ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1414264 ;PMID: 25692915

Full text available

3
Pharmacology of Corticosteroids for Diabetic Macular Edema
Material Type:
Article
Add to My Research

Pharmacology of Corticosteroids for Diabetic Macular Edema

Investigative ophthalmology & visual science, 2018-01, Vol.59 (1), p.1-12 [Peer Reviewed Journal]

Copyright 2018 The Authors 2018 ;ISSN: 1552-5783 ;ISSN: 0146-0404 ;EISSN: 1552-5783 ;DOI: 10.1167/iovs.17-22259 ;PMID: 29297055

Full text available

4
Effect of Intravitreous Anti–Vascular Endothelial Growth Factor vs Sham Treatment for Prevention of Vision-Threatening Complications of Diabetic Retinopathy: The Protocol W Randomized Clinical Trial
Material Type:
Article
Add to My Research

Effect of Intravitreous Anti–Vascular Endothelial Growth Factor vs Sham Treatment for Prevention of Vision-Threatening Complications of Diabetic Retinopathy: The Protocol W Randomized Clinical Trial

Archives of ophthalmology (1960), 2021-07, Vol.139 (7), p.701 [Peer Reviewed Journal]

Copyright American Medical Association Jul 2021 ;ISSN: 2168-6165 ;EISSN: 1538-3601 ;DOI: 10.1001/jamaophthalmol.2021.0606

Full text available

5
Early and Long-term Responses to Anti-Vascular Endothelial Growth Factor Therapy in Diabetic Macular Edema: Analysis of Protocol I Data
Material Type:
Article
Add to My Research

Early and Long-term Responses to Anti-Vascular Endothelial Growth Factor Therapy in Diabetic Macular Edema: Analysis of Protocol I Data

American journal of ophthalmology, 2016-12, Vol.172, p.72-79 [Peer Reviewed Journal]

2016 The Authors ;Copyright © 2016 The Authors. Published by Elsevier Inc. All rights reserved. ;Copyright Elsevier Limited Dec 01, 2016 ;ISSN: 0002-9394 ;EISSN: 1879-1891 ;DOI: 10.1016/j.ajo.2016.09.012 ;PMID: 27644589 ;CODEN: AJOPAA

Full text available

6
Diabetic retinopathy and diabetic macular oedema pathways and management: UK Consensus Working Group
Material Type:
Article
Add to My Research

Diabetic retinopathy and diabetic macular oedema pathways and management: UK Consensus Working Group

Eye (London), 2020-06, Vol.34 (Suppl 1), p.1-51 [Peer Reviewed Journal]

The Author(s), under exclusive licence to The Royal College of Ophthalmologists 2020. ;The Author(s), under exclusive licence to The Royal College of Ophthalmologists 2020 ;ISSN: 0950-222X ;EISSN: 1476-5454 ;DOI: 10.1038/s41433-020-0961-6 ;PMID: 32504038

Full text available

7
Visual acuity outcomes and anti-VEGF therapy intensity in diabetic macular oedema: a real-world analysis of 28 658 patient eyes
Material Type:
Article
Add to My Research

Visual acuity outcomes and anti-VEGF therapy intensity in diabetic macular oedema: a real-world analysis of 28 658 patient eyes

British journal of ophthalmology, 2021-02, Vol.105 (2), p.216-221 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;2021 Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. 2021 ;ISSN: 0007-1161 ;EISSN: 1468-2079 ;DOI: 10.1136/bjophthalmol-2020-315933 ;PMID: 32265201

Full text available

8
Association of Predominantly Peripheral Lesions on Ultra-Widefield Imaging and the Risk of Diabetic Retinopathy Worsening Over Time
Material Type:
Article
Add to My Research

Association of Predominantly Peripheral Lesions on Ultra-Widefield Imaging and the Risk of Diabetic Retinopathy Worsening Over Time

Archives of ophthalmology (1960), 2022-10, Vol.140 (10), p.946 [Peer Reviewed Journal]

Copyright American Medical Association Oct 2022 ;ISSN: 2168-6165 ;EISSN: 1538-3601 ;DOI: 10.1001/jamaophthalmol.2022.3131

Full text available

9
Ranibizumab 0.5 mg treat-and-extend regimen for diabetic macular oedema: the RETAIN study
Material Type:
Article
Add to My Research

Ranibizumab 0.5 mg treat-and-extend regimen for diabetic macular oedema: the RETAIN study

British journal of ophthalmology, 2016-06, Vol.100 (6), p.787-795 [Peer Reviewed Journal]

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing ;Copyright: 2016 Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/ 2016 ;ISSN: 0007-1161 ;EISSN: 1468-2079 ;DOI: 10.1136/bjophthalmol-2015-307249 ;PMID: 26453639 ;CODEN: BJOPAL

Full text available

10
Association of Ultra-Widefield Fluorescein Angiography–Identified Retinal Nonperfusion and the Risk of Diabetic Retinopathy Worsening Over Time
Material Type:
Article
Add to My Research

Association of Ultra-Widefield Fluorescein Angiography–Identified Retinal Nonperfusion and the Risk of Diabetic Retinopathy Worsening Over Time

Archives of ophthalmology (1960), 2022-10, Vol.140 (10), p.936 [Peer Reviewed Journal]

Copyright American Medical Association Oct 2022 ;ISSN: 2168-6165 ;EISSN: 1538-3601 ;DOI: 10.1001/jamaophthalmol.2022.3130

Full text available

11
Safety and Efficacy of Ranibizumab in Diabetic Macular Edema (RESOLVE Study): A 12-month, randomized, controlled, double-masked, multicenter phase II study
Material Type:
Article
Add to My Research

Safety and Efficacy of Ranibizumab in Diabetic Macular Edema (RESOLVE Study): A 12-month, randomized, controlled, double-masked, multicenter phase II study

Diabetes care, 2010-11, Vol.33 (11), p.2399-2405 [Peer Reviewed Journal]

2015 INIST-CNRS ;COPYRIGHT 2010 American Diabetes Association ;Copyright American Diabetes Association Nov 2010 ;2010 by the American Diabetes Association. ;ISSN: 0149-5992 ;EISSN: 1935-5548 ;DOI: 10.2337/dc10-0493 ;PMID: 20980427 ;CODEN: DICAD2

Full text available

12
NSAIDs and Corticosteroids for the Postoperative Management of Age-Related Cataract Surgery: A Systematic Review and Meta-analysis
Material Type:
Article
Add to My Research

NSAIDs and Corticosteroids for the Postoperative Management of Age-Related Cataract Surgery: A Systematic Review and Meta-analysis

American journal of ophthalmology, 2024-04, Vol.260, p.1-13 [Peer Reviewed Journal]

2023 Elsevier Inc. ;Copyright © 2023 Elsevier Inc. All rights reserved. ;ISSN: 0002-9394 ;EISSN: 1879-1891 ;DOI: 10.1016/j.ajo.2023.09.027 ;PMID: 37797866

Full text available

13
Anti-IL6-Receptor Tocilizumab in Refractory and Noninfectious Uveitic Cystoid Macular Edema: Multicenter Study of 25 Patients
Material Type:
Article
Add to My Research

Anti-IL6-Receptor Tocilizumab in Refractory and Noninfectious Uveitic Cystoid Macular Edema: Multicenter Study of 25 Patients

American journal of ophthalmology, 2019-04, Vol.200, p.85-94 [Peer Reviewed Journal]

2019 Elsevier Inc. ;Copyright © 2019 Elsevier Inc. All rights reserved. ;2019. Elsevier Inc. ;ISSN: 0002-9394 ;EISSN: 1879-1891 ;DOI: 10.1016/j.ajo.2018.12.019 ;PMID: 30660771

Full text available

14
Anti-vascular endothelial growth factor for diabetic macular oedema
Material Type:
Article
Add to My Research

Anti-vascular endothelial growth factor for diabetic macular oedema

Cochrane database of systematic reviews, 2014-10 (10), p.CD007419-CD007419 [Peer Reviewed Journal]

EISSN: 1469-493X ;DOI: 10.1002/14651858.CD007419.pub4 ;PMID: 25342124

Full text available

15
Long-Term Visual Outcomes and Morphologic Biomarkers of Vision Loss in Eyes With Diabetic Macular Edema Treated With Anti-VEGF Therapy
Material Type:
Article
Add to My Research

Long-Term Visual Outcomes and Morphologic Biomarkers of Vision Loss in Eyes With Diabetic Macular Edema Treated With Anti-VEGF Therapy

American journal of ophthalmology, 2022-03, Vol.235, p.80-89 [Peer Reviewed Journal]

2021 Elsevier Inc. ;Copyright © 2021 Elsevier Inc. All rights reserved. ;2021. Elsevier Inc. ;ISSN: 0002-9394 ;EISSN: 1879-1891 ;DOI: 10.1016/j.ajo.2021.09.002 ;PMID: 34509431

Full text available

16
Five-year visual acuity outcomes and injection patterns in patients with pro-re-nata treatments for AMD, DME, RVO and myopic CNV
Material Type:
Article
Add to My Research

Five-year visual acuity outcomes and injection patterns in patients with pro-re-nata treatments for AMD, DME, RVO and myopic CNV

British journal of ophthalmology, 2017-03, Vol.101 (3), p.353-359 [Peer Reviewed Journal]

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/. ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/2017This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See:http://creativecommons.org/licenses/by-nc/4.0 ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/ 2017 ;ISSN: 0007-1161 ;EISSN: 1468-2079 ;DOI: 10.1136/bjophthalmol-2016-308668 ;PMID: 27215744

Full text available

17
Long-term efficacy and safety profile of multiple injections of intravitreal dexamethasone implant to manage diabetic macular edema: A systematic review of real-world studies
Material Type:
Article
Add to My Research

Long-term efficacy and safety profile of multiple injections of intravitreal dexamethasone implant to manage diabetic macular edema: A systematic review of real-world studies

Journal of pharmacological sciences, 2018-12, Vol.138 (4), p.219-232 [Peer Reviewed Journal]

2018 The Authors ;Copyright © 2018 The Authors. Production and hosting by Elsevier B.V. All rights reserved. ;ISSN: 1347-8613 ;EISSN: 1347-8648 ;DOI: 10.1016/j.jphs.2018.11.001 ;PMID: 30503676

Full text available

18
Association Between Soluble CD14 in the Aqueous Humor and Hyperreflective Foci on Optical Coherence Tomography in Patients With Diabetic Macular Edema
Material Type:
Article
Add to My Research

Association Between Soluble CD14 in the Aqueous Humor and Hyperreflective Foci on Optical Coherence Tomography in Patients With Diabetic Macular Edema

Investigative ophthalmology & visual science, 2018-02, Vol.59 (2), p.715-721 [Peer Reviewed Journal]

ISSN: 1552-5783 ;EISSN: 1552-5783 ;DOI: 10.1167/iovs.17-23042 ;PMID: 29392317

Full text available

19
Early Response to Anti–Vascular Endothelial Growth Factor and Two-Year Outcomes Among Eyes With Diabetic Macular Edema in Protocol T
Material Type:
Article
Add to My Research

Early Response to Anti–Vascular Endothelial Growth Factor and Two-Year Outcomes Among Eyes With Diabetic Macular Edema in Protocol T

American journal of ophthalmology, 2018-11, Vol.195, p.93-100 [Peer Reviewed Journal]

2018 Elsevier Inc. ;Copyright © 2018 Elsevier Inc. All rights reserved. ;COPYRIGHT 2018 Elsevier B.V. ;Copyright Elsevier Limited Nov 2018 ;ISSN: 0002-9394 ;EISSN: 1879-1891 ;DOI: 10.1016/j.ajo.2018.07.030 ;PMID: 30077569

Full text available

20
KESTREL and KITE Phase 3 Studies: 100-Week Results With Brolucizumab in Patients With Diabetic Macular Edema
Material Type:
Article
Add to My Research

KESTREL and KITE Phase 3 Studies: 100-Week Results With Brolucizumab in Patients With Diabetic Macular Edema

American journal of ophthalmology, 2024-04, Vol.260, p.70-83 [Peer Reviewed Journal]

2023 The Author(s) ;Copyright © 2023 The Author(s). Published by Elsevier Inc. All rights reserved. ;ISSN: 0002-9394 ;EISSN: 1879-1891 ;DOI: 10.1016/j.ajo.2023.07.012 ;PMID: 37460036

Full text available

Results 1 - 20 of 1,884  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Peer-reviewed Journals (1,746)

Refine My Results

Creation Date 

From To
  1. Before 1996  (9)
  2. 1996 To 2002  (41)
  3. 2003 To 2009  (393)
  4. 2010 To 2017  (841)
  5. After 2017  (601)
  6. More options open sub menu

Resource Type 

  1. Articles  (1,878)
  2. Book Chapters  (6)
  3. More options open sub menu

Language 

  1. English  (1,792)
  2. Japanese  (224)
  3. Spanish  (35)
  4. Portuguese  (34)
  5. French  (30)
  6. German  (25)
  7. Czech  (3)
  8. Swedish  (2)
  9. Turkish  (2)
  10. Norwegian  (1)
  11. Serbian  (1)
  12. Korean  (1)
  13. Icelandic  (1)
  14. More options open sub menu

Searching Remote Databases, Please Wait